100 项与 Hawker Resources, Inc. 相关的临床结果
0 项与 Hawker Resources, Inc. 相关的专利(医药)
2004-01-01·SYNTHESIS-STUTTGART
Large-Scale Chemical and Enzymatic Synthesis of a
Clostridium difficile
Toxin A Binding Trisaccharide
作者: Kamath, Vivekanand P. ; Fang, Ying R. ; Palcic, Monica M. ; Gregson, Jonathan M. ; Yeske, Robert E. ; Ratcliffe, R. Murray
8-Methoxycarbonyloctyl-O-(α-D-galactopyranosyl)-(1→3)-(β-D-galactopyranosyl)-(1→4)-β-D-glucopyranoside, linked to a solid support can be used to remove Clostridium difficile toxin A from the intestinal tract.Therefore, multi-gram chem. and enzymic synthesis of the toxin binding trisaccharide from 8-methoxycarbonyloctyl β-lactoside disaccharide were explored.Chem. conversion in 30% overall yield could be achieved in seven steps.Alternatively a single step enzymic conversion of the lactoside using recombinant α(1→3)-galactosyltransferase with UDP-galactose or UDP-glucose/UDP-Glc epimerase gave the desired trisaccharide in 85-90% yield.
100 项与 Hawker Resources, Inc. 相关的药物交易
100 项与 Hawker Resources, Inc. 相关的转化医学